Overview

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study of varenicline 2.0 mg/day treatment for 2 weeks with smoking test done in laboratory on Day 8 and a 1 week quit attempt from Day 8-14.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Collaborator:
Pfizer
Treatments:
Varenicline